13. 多発性硬化症/視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details


臨床試験数 : 3,340 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05417269
(ClinicalTrials.gov)
April 12, 20221/6/2022IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS StudyA Phase I/II Dose Escalation/Adaptive Design Study to Evaluate the Safety and Efficacy of IMCY-0141 in Patients With Relapsing Remitting-Multiple Sclerosis (RR-MS)Multiple Sclerosis, Relapsing-RemittingDrug: IMCY-0141;Drug: Placebo;Drug: Dimethyl FumarateImcyse SANULLRecruiting18 Years45 YearsAll150Phase 1/Phase 2Moldova, Republic of